Matinas BioPharma Holdings, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.88 | -100% | -9.07 | -100% |
| P/S |
|
43.41 | 4.07 | 967.28% |
|
|
| P/BV |
|
2.47 | 9.4 | -73.69% |
|
|
| P/FCF |
|
0 | 46.57 | -100% |
|
|
| Ev/Ebitda |
|
-2.03 | 17.62 | -111.51% |
|
|
| Ev/S |
|
42.24 | 4.37 | 866.91% |
|
|
| Ev/FCF |
|
-2.99 | 54.59 | -105.47% |
|
|
| E/P |
|
0 | 0.2164 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-2082.57 | 20.15 | -10436.34% | -23828.33 | -91.26% |
| ROE |
|
-119.2 | -80.86 | 47.43% |
|
|
| ROA |
|
-34.98 | 6.71 | -621.05% |
|
|
| ROIC |
|
0 | 15.68 | -100% |
|
|
| ROS |
|
-2093.25 | 10.55 | -19931.84% |
|
|
| ROCE |
|
-123.49 | 18.05 | -784.08% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1558 | 2.87 | -105.42% | -0.1636 | -4.77% |
| Nеt Debt/Ebitda |
|
0.0561 | 3.69 | -98.48% |
|
|
| Debt/Ratio |
|
0.0542 | 0.2643 | -79.48% |
|
|
| Debt/Equity |
|
1.69 | 4.83 | -64.95% |
|
|
| Debt/Net Income |
|
-0.155 | 6.45 | -102.4% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.31 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 6.33 | -100% | ||
| DSI |
|
0 | 0.7376 | -100% |
|
|
| Average dividend growth |
|
0 | -3.12 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.29 | -100% |
|
|
| Average percentage for payments |
|
0 | 77.61 | -100% |
|
|
| Difference from average difference in sector |
|
-1.31 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
1117.78 | 362.86 | 208.05% | ||
| Growth impulse Ebitda in 5 years |
|
14.7 | 373.75 | -96.07% | ||
| Growth impulse Net Income in 5 years |
|
47.06 | 454.84 | -89.65% | ||
| Growth impulse FCF in 5 years |
|
6.87 | 306.17 | -97.76% | ||
| Growth impulse EPS in 5 years |
|
4820.54 | 455.99 | 957.16% |
IP Score
3.86/10
